Form 4: LeMaitre Vascular CFO Joseph Pellegrino Jr. Reports Stock Transactions
SEC Form 4 Filing
Joseph Pellegrino Jr., CFO of LeMaitre Vascular, reports acquisition and disposal of common stock and dividend equivalent rights related to performance share units.
Summary
- On February 28, 2025, Joseph Pellegrino Jr., Chief Financial Officer of LeMaitre Vascular, reported transactions involving the company's common stock.
- Pellegrino acquired 685 shares of common stock upon settlement of a Performance Share Unit (PSU) award granted on December 8, 2023, at a price of $0.
- He also acquired 5 shares upon the release of dividend equivalent rights.
- Additionally, 203 shares were disposed of to satisfy tax withholding obligations at a price of $91.85 per share.
- Following these transactions, Pellegrino beneficially owns 9,566 shares of LeMaitre Vascular common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the filing reflects routine transactions related to executive compensation and tax obligations. There is no indication of unusual or concerning activity.
Positives
- Acquisition of shares through PSU vesting indicates alignment with company performance goals.
Negatives
- Disposal of shares to cover tax obligations reduces the overall holdings.
Risks
- Future tax obligations related to vesting equity may lead to further disposal of shares.
Future Outlook
The PSU award continues to vest in annual installments, which will likely result in future Form 4 filings.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. This filing indicates normal compensation and tax-related transactions.
Comparison to Industry Standards
- Monitoring insider transactions is a standard practice in financial analysis.
- Comparing Pellegrino's holdings and transactions to those of CFOs at comparable medical device companies (e.g., Medtronic, Boston Scientific) can provide insights into executive compensation and alignment with shareholder interests.
- Similar PSU vesting schedules and tax withholding practices are common across publicly traded companies.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders.
- Transparency in insider trading activity can foster investor confidence.
Next Steps
- Monitor future Form 4 filings related to the ongoing vesting of the PSU award.
- Track Pellegrino's ownership stake for any significant changes.
Key Dates
| Date | Description |
|---|---|
| December 4, 2024 | Date of Limited Power of Attorney execution. |
| December 8, 2023 | Date of grant for the Performance Share Unit (PSU) award. |
| February 28, 2025 | Date of stock transactions (acquisition and disposal) and release of dividend equivalent rights. |
| March 04, 2025 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.